2026 Annual Meeting | H74 - The Neurology of Religion (HeadTalks)
Date
Sunday 04/19/26
Time
01:45 PM - 02:30 PM CDT
Add To Calendar
Location
McCormick Place West | F2 Lobby
Session Format
This program will be presented both in-person and online
On Demand
This program will be available in the meeting's On Demand product.
Event Type
Hubs (HeadTalks)
Director(s)
Mario F. Peres, MD
Topic(s)
General Neurology
Learning Objectives
Join us as we explore explanatory models of disease that integrate biomedical, cultural, and religious frameworks, and learn how to apply these models in patient-centered care. Faculty will summarize what science has discovered about the interaction between religiosity, spirituality, and neurological disorders, drawing from clinical studies, neuroimaging, and transcultural research. Envision a path for the future by identifying opportunities for research, education, and clinical practice that bridge neuroscience, spirituality, and global health.
CME Available
No CME available
Core Competencies
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Systems-based Practice, Quality Improvement
Program Level
Intermediate
Recommended Audience
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator, Coordinator
Teaching Styles
Didactic
Program Materials
Program Evaluations
Event Timeline
01:45 PM - 02:30 PM CDT
Speaker
The Neurology of Religion
Mario F. Peres, MD
Faculty Disclosures
Mario F. Peres, MD
Dr. Peres has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eurofarma. Dr. Peres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Peres has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Libbs. Dr. Peres has received research support from CNPq. Dr. Peres has received research support from Allergan.